Key facts
- This page summarizes Elaine M. Shannon's Form 4 filing for TAKEDA PHARMACEUTICAL CO LTD (TAK).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2026, 16:10.
Elaine M. Shannon - 11 Aug 2026 Form 4 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Reporting relationship
- Pres., Global Supply & Quality
- Issuer ticker
- TAK
- Reported as of
- 11 Aug 2026
- Net transaction value
- -$357,371
- SEC form
- 4
- Accepted by SEC
- 12 Aug 2026, 16:10:02 UTC
- Prior SEC filing
- 12 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Samuel Ntonme, by power of attorney, for Elaine M. Shannon
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Elaine M. Shannon filed Form 4 for TAKEDA PHARMACEUTICAL CO LTD (TAK) on 12 Aug 2026.
Change
- Previous filing in this sequence was filed on 12 Aug 2026.
- Current net transaction value: -$357,371.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002009368
Primary reporting owner
Shannon Elaine Mary
- Relationship
- Pres., Global Supply & Quality
- Address
- 45-55 HAYDEN AVENUE, LEXINGTON
- Signature
- /s/ Samuel Ntonme, by power of attorney, for Elaine M. Shannon
- Signature date
- 12 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TAK
transaction
American Depositary Shares
Sale
- Transaction value
- $357,371
- Shares
- -20,363
- Change %
- -23%
- Price
- $17.55
- Shares after
- 67,311
- Date
- 11 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.